Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.
D015120:6-Aminonicotinamide / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002460:Cell Line; D005910:Glioma / Q000378:metabolism*; D005942:Gluconates / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D005958:Glucosephosphates / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism*; D009536:Niacinamide / Q000031:analogs & derivatives*; D010428:Pentosephosphates / Q000378:metabolism*; D051381:Rats
D005942:Gluconates; D005958:Glucosephosphates; D007773:Lactates; D010428:Pentosephosphates; D009536:Niacinamide; D015120:6-Aminonicotinamide; D005947:Glucose